Shell Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
Shell Asset Management's BLUE Position: Q2 2022 in Review
Shell Asset Management sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 859 shares — an estimated $83K sold.
Shell Asset Management first reported a position in BLUE in Q4 2017 and held it in 18 quarters. The position peaked at $1.01M in Q4 2017. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- Shell Asset Management reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
- Shell Asset Management sold 859 bluebird bio shares in Q2 2022, an estimated $83K.
- Shell Asset Management first reported a position in bluebird bio in Q4 2017 and held it in 18 quarters.
- Shell Asset Management's bluebird bio position peaked at $1.01M in Q4 2017.
- 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on Shell Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.